SI
SI
Advertise on SI

 Biotech / Medical | The Stock for 1999(Polymedica)PLMD(Medical Supply Co.)


Previous 10 | Next 10 
To: Mike E. who wrote (3363)8/23/2001 12:40:15 AM
From: Pluvia   of 3414
 
How long before...

1. Auditor bails (due to liability exposure), and pulls past opinions on 10k's... Causing stock to be halted for months until new financials are filed... Causing company to run out of working capital...

2. Medicare eliminates PLMD as a provider... Causing PLMD to implode...

PLMD looks like a zero to me. Buyer beware, there is absolutely NO reason to own this stock imo...

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (2)

To: Pluvia who wrote (3364)8/23/2001 9:17:03 AM
From: D.Austin   of 3414
 
Hellllooooo Pluvia-I am saddened that you of all people
have joined us.You have been missing in action for months,
other than your debut on TV.And you find a compelling reason
to pop in on the PLMD board.
I knew PLMD was to good to be true--the growth rates going forward--- revenue,net income,ROE,ROA,ROIC--increases.

the low debt/equity ratio--the long debt/equity ratio--the
low P/E,P/& PEG the lowest in this industry.




$ in millions 92 93 94 95 96 97 98 99 00 01
Revenue 2.8 11 22.5 27 24.8 30.5 73.8 104.8 156.9 220
Net Income -3.8 -3.9 -0.4 1.8 3.1 2.3 7.6 7.6 16.5 29.7
Cash Flow -3.2 -2.3 3.3 5.4 5.8 5.5 13.3 16.3 29.5 54.5

Taken from QUICKEN.com

• Insights: Given the above earnings and discount rate, PLMD must grow earnings at a rate of -9.8% annually for 10 years to justify its current stock price of $11.25. You can adjust the earnings growth rate and discount rate to see how they can dramatically alter PLMD's intrinsic value per share.

• Walk through: If we assume initial earnings of $31.9 million grow at a rate of 28.00%, and we discount those future earnings at a rate of 15.00%, we arrive at a net present value for the company's next 10 years of earnings of $603 million. To account for potential earnings beyond the 10th year, we estimate a growth rate of 6.00%, a discount rate of 12.00%, and we arrive at a continuing value of $1.99 billion. To complete the calculation we add these two figures together, subtract the long-term debt for PLMD ($2.90 million), and divide by the outstanding shares (13.0 million) to get a per share intrinsic value of $199.58.

• Considerations: Gauging the future growth and risk outlook of a company such as PLMD, however, is more art than science. New products, management, or strategic directions can fuel growth far above historic norms. Likewise, unforeseen setbacks can cut a company's future value in half. Have PLMD's earnings slowed or accelerated in the past year from its 5-year average? How fast do analysts expect it to grow in the next year or two? How great are the risks it faces? Be sure to check PLMD's financials and recent news stories on the company. Also compare it to other companies in its industry.
KEY WORDS HERE
Be sure to check PLMD's financials and recent news stories on the company
Be sure to check PLMD's financials and recent news stories on the company.
Be sure to check PLMD's financials and recent news stories on the company.

All I can say is thank you for your input its appreciated by me at least.
I'm outahere---Dennis

P.S.it was bad enough when Auric showed up.....
quicken.com 

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

To: Pluvia who wrote (3364)8/23/2001 10:12:09 AM
From: Bruce A. Brotnov   of 3414
 
Pluvia - last time I heard you was a personal guarantee that COII would drop to .25. I'm still waiting as I think it was around 4 last look (new symbol though). Is this another personal guarantee for your followers that PLMD will go to 0?

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

To: Bruce A. Brotnov who wrote (3366)8/23/2001 11:42:45 AM
From: Pluvia   of 3414
 
Pluvia - last time I heard you was a personal guarantee that COII would drop to .25.

Bruce,

maybe you could link me to this apparent "guarantee" as I don't recall it, and I don't make guarantees... COII is a worthless pos imo. That make you happy?

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

To: D.Austin who wrote (3365)8/23/2001 11:51:17 AM
From: Pluvia   of 3414
 
Dennis,

The numbers you quote are very old.

1. How much cash will be used to re-pay medicare?
2. How much cash was used to buy back shares?
3. How much A/R is BS due to fraudulent billing?
4. if the stock is halted and forced to re-state financials, (which I think is likely), they can't raise cash...
5. With no ability to bill medicare, no ability to rasie additional cash, big legal bills, and medicare fines, how do the numbers look?

I've seen medicare go after companies in the past. None I've seen with this level of investigation are allowed by medicare to continue acting as a medicare provider.

How do you like the PLMD business plan if PLMD can't do business with medicare patients?

Good luck, and buyer beware.

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

To: Pluvia who wrote (3367)8/23/2001 12:59:35 PM
From: Bruce A. Brotnov   of 3414
 
Ok - maybe you didn't give a personal guarantee - but a 12 month target, unless it was in following discussions:

"To:scott clark who wrote (4071)
From: Pluvia Thursday, Jun 22, 2000 6:33 AM
View Replies (8) | Respond to of 5982

LAS VEGAS -- June 22, Pluvia Securities Research Initiates Coverage of Computerized Thermal Imaging, Inc., (OTC Bulletin Board: COII), with a STRONG SELL Recommendation at the current price of $9.125, giving a 12 month price target of under $0.25 cents."

You restated the target in Message 4168 (here on SI) that target of less than 0.25 in 12 months. That was over 12 months ago, did it ever get under $1.?

Is your target for PLMD of 0.00 also within 12 months?

BTW: how many of those 8 million short shares of PLMD are owned by PLUVIA organization? You must need a wheel barrow to take to the bank. <g>

Just wondering again,

Bruce

Share Recommend | Keep | Reply | Mark as Last Read

To: Pluvia who wrote (3368)8/24/2001 8:43:41 PM
From: RGM   of 3414
 
This situation appears to be similar to what happened to Columbia Hospitals (now HCA, formerly COL) a couple of years ago.

Tell me how you know what you posted in your message #3368 to be true (facts only please). I know you are short a whole bunch of PLMD shares. Congratulations on calling this stock a short at higher prices.

This stock shall drop further if and when the govt. issues indictments against this company. I wonder how long it shall take for them to analyze all of those seized documents, computers, etc., conduct interviews of company personnel resulting in evidence and identification of the personnel who committed these alleged crimes.

Do you recall how long the turnaround time was for the govt. to issue indictments after they seizing similar stuff from the raided Columbia Hospitals in Florida?

Worst Case - My guess is that PLMD shall end up the same way that HCA did with $ penalties and with the identified managers served with criminal indictments. It took about year for Columbia to move up from the low 20's. Why would the worst case scenario be different for PLMD versus the similar situation for Columbia Hospitals?

I don't care about you posting messages here and on Yahoo warning the readers to sell this stock, however, you place yourself in the same lowlife class as the novice investor or trader who also shorted this stock (otherwise known as a "jerk") and then post messages on the boards trying to scare longs in selling their shares WHEN YOU DO NOT PROVIDE THE FACTS TO BACK UP YOUR STATEMENTS, such as in your message #3368.

I do not currently own any long or short shares of PLMD, but I intend to buy long shares in the single digit range via puts that I sold if and when indictments are served.

Have a nice day,

Rob

Share Recommend | Keep | Reply | Mark as Last Read

To: Arthur Radley who started this subject9/2/2001 8:32:16 PM
From: D.Austin   of 3414
 
archiving

fortune.com 

Share Recommend | Keep | Reply | Mark as Last Read

To: Arthur Radley who started this subject9/10/2001 9:29:13 AM
From: D.Austin   of 3414
 
Medicare Respiratory Billing Adjustments Expected to Result in a Charge
WOBURN, Mass.--(BUSINESS WIRE)--Sept. 10, 2001-- PolyMedica Corporation (NNM:PLMD) today reaffirmed its previous net revenue guidance of $275 million for fiscal 2002 and $68 - $69 million for the second quarter ending September 30, 2001. PolyMedica's core business remains strong with increased demand for diabetes and respiratory supplies from a growing base of loyal customers


just be happy

Because PolyMedica expects to incur unusual legal and related expenses in the current fiscal quarter and because of the overpayment notices described below, PolyMedica is not able to provide earnings guidance. The legal and related expenses of approximately $0.10-$0.14 per share diluted in the second quarter are attributable to previously reported investigations of its subsidiaries Liberty Medical Supply and Liberty Home Pharmacy.

Call your broker

Since September 1999, PolyMedica has been reimbursed by all four DMERCs based on its present pricing formula and previously had received no overpayment notices disputing that formula.

Because of the above overpayment notices, the Company expects to expense between $800,000 and $1.0 million as a period cost in the current quarter, subject to possible recovery in a later period if such amount is ultimately determined to have been correctly billed by the Company.

Look how that statement cleared up the situation

If one or more of the other three DMERCs express a similar position, the Company will expense up to an additional $5.0-$5.5 million in the appropriate period(s

Now trading @ 12.80
order confussion----trade-12.05-bid 12.30 ask 12.60

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

To: D.Austin who wrote (3372)10/9/2001 10:08:45 AM
From: D.Austin   of 3414
 
This stock is going to 27 near term.Partial GTC order in @ 26.25......IMHO D.A.

Share Recommend | Keep | Reply | Mark as Last Read
Previous 10 | Next 10 

Copyright © 1995-2013 Knight Sac Media. All rights reserved.